Clinical Trial

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study or is to explore the correlation between dynamic changes in postoperative circulating tumor DNA (ctDNA) and recurrence risk using a novel, tumor-informed ctDNA detection technique, thus laying the foundation for further promoting ctDNA detection to guide postoperative adjuvant therapy decisions. This study focuses on patients with esophageal squamous cell carcinoma who did not achieve pCR following neoadjuvant therapy combined with surgical resection. The main question it aims to answer is: Is there a correlation between postoperative ctDNA changes and tumor recurrence? Participants will be asked to undergo postoperative ctDNA detection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-17.
Status change: Not Yet Recruiting → Recruiting 2024-08-27
Trial Details
NCT Number NCT06561178
Lead Sponsor Sun Yat-Sen University Cancer Center
Conditions Esophageal Squamous Cell Carcinoma
Enrollment 50 participants
Start Date 2024-08-26
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-29